| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/25/2023 | 40.47% | BTIG | → $16 | Initiates Coverage On | → Buy |
| 12/21/2022 | 31.69% | Jefferies | → $15 | Initiates Coverage On | → Buy |
| 11/10/2022 | 14.14% | Morgan Stanley | → $13 | Initiates Coverage On | → Equal-Weight |
| 10/18/2022 | 58.03% | UBS | → $18 | Initiates Coverage On | → Buy |
| 10/14/2022 | 40.47% | Citigroup | → $16 | Initiates Coverage On | → Buy |
| 09/02/2022 | — | Evercore ISI Group | Initiates Coverage On | → Outperform |
What is the target price for ProKidney (PROK)?
The latest price target for ProKidney (NASDAQ: PROK) was reported by BTIG on July 25, 2023. The analyst firm set a price target for $16.00 expecting PROK to rise to within 12 months (a possible 40.47% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ProKidney (PROK)?
The latest analyst rating for ProKidney (NASDAQ: PROK) was provided by BTIG, and ProKidney initiated their buy rating.
When is the next analyst rating going to be posted or updated for ProKidney (PROK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ProKidney, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ProKidney was filed on July 25, 2023 so you should expect the next rating to be made available sometime around July 25, 2024.
Is the Analyst Rating ProKidney (PROK) correct?
While ratings are subjective and will change, the latest ProKidney (PROK) rating was a initiated with a price target of $0.00 to $16.00. The current price ProKidney (PROK) is trading at is $11.39, which is within the analyst's predicted range.